Pangrol Lipazy (Amylase, Lipase, Protease)

Pangrol Lipazy is used to replace deficient digestive enzymes in conditions affecting pancreatic exocrine function.

• Exocrine pancreatic insufficiency: improves digestion and nutrient absorption by supplying missing enzymes.
• Cystic fibrosis: aids digestion by compensating for pancreatic enzyme deficiency common in CF patients.
• Chronic pancreatitis: supports nutrient breakdown when pancreatic output is reduced.
• Malabsorption syndromes: enhances macronutrient hydrolysis in various malabsorption conditions.

• Pangrol Lipazy provides exogenous amylase, lipase, and protease that act directly in the gastrointestinal lumen. Amylase catalyzes the hydrolysis of starches to sugars, lipase hydrolyzes triglycerides to fatty acids and monoglycerides, and protease cleaves peptide bonds in proteins, thereby compensating for insufficient endogenous pancreatic secretion and facilitating nutrient absorption. These enzymes remain active across the pH range of the duodenum and are formulated to resist gastric degradation, ensuring delivery to the small intestine where they exert their catalytic activity.

Common Side Effects

• Abdominal discomfort: mild pain or cramping in the upper abdomen.
• Flatulence: increased gas production leading to bloating.
• Diarrhea: loose stools occurring after dosing.
• Nausea: feeling of queasiness without vomiting.
• Constipation: reduced bowel movements.
• Taste alteration: temporary change in flavor perception.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Severe abdominal pain: intense pain that may indicate pancreatitis.
• Eosinophilic colitis: inflammation of the colon with eosinophil infiltration.
• Intestinal obstruction: blockage symptoms such as vomiting and inability to pass gas.
• Hypersensitivity pneumonitis: rare lung inflammation after inhalation of powder residues.

Before initiating therapy, evaluate pancreatic exocrine function and nutritional status.

• Assess pancreatic function: confirm deficiency to justify enzyme replacement.
• Monitor nutritional status: track weight, vitamin levels, and stool fat content.
• Adjust dose based on clinical response: titrate to achieve optimal symptom control.
• Avoid in known hypersensitivity: do not use if the patient has documented allergy to any enzyme component.
• Use with caution in gastrointestinal disorders: consider underlying motility or inflammatory conditions.
• Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Major Interactions (Avoid)

• Concurrent use with other pancreatic enzyme products: may lead to excessive enzyme exposure.
• Co‑administration with cholestyramine or other bile‑acid sequestrants: can bind enzymes and reduce efficacy.
• High‑dose antacids containing aluminum or magnesium: may inactivate enzyme activity.

Moderate Interactions (Monitor Closely)

• Fat‑soluble vitamin supplementation (A, D, E, K): monitor levels as enzyme therapy can alter absorption.
• Oral contraceptives: assess for potential changes in hormone absorption.
• Broad‑spectrum antibiotics: may affect gut flora and indirectly influence enzyme effectiveness.